United States Cystic Fibrosis Drugs Market Report 2018

Table of Contents

United States Cystic Fibrosis Drugs Market Report 2018
1 Cystic Fibrosis Drugs Overview
1.1 Product Overview and Scope of Cystic Fibrosis Drugs
1.2 Classification of Cystic Fibrosis Drugs by Product Category
1.2.1 United States Cystic Fibrosis Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Cystic Fibrosis Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Oral
1.2.4 Injection
1.3 United States Cystic Fibrosis Drugs Market by Application/End Users
1.3.1 United States Cystic Fibrosis Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 United States Cystic Fibrosis Drugs Market by Region
1.4.1 United States Cystic Fibrosis Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Cystic Fibrosis Drugs Status and Prospect (2013-2025)
1.4.3 Southwest Cystic Fibrosis Drugs Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Cystic Fibrosis Drugs Status and Prospect (2013-2025)
1.4.5 New England Cystic Fibrosis Drugs Status and Prospect (2013-2025)
1.4.6 The South Cystic Fibrosis Drugs Status and Prospect (2013-2025)
1.4.7 The Midwest Cystic Fibrosis Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Cystic Fibrosis Drugs (2013-2025)
1.5.1 United States Cystic Fibrosis Drugs Sales and Growth Rate (2013-2025)
1.5.2 United States Cystic Fibrosis Drugs Revenue and Growth Rate (2013-2025)

2 United States Cystic Fibrosis Drugs Market Competition by Players/Suppliers
2.1 United States Cystic Fibrosis Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Cystic Fibrosis Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Cystic Fibrosis Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Cystic Fibrosis Drugs Market Competitive Situation and Trends
2.4.1 United States Cystic Fibrosis Drugs Market Concentration Rate
2.4.2 United States Cystic Fibrosis Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cystic Fibrosis Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cystic Fibrosis Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Cystic Fibrosis Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Cystic Fibrosis Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Cystic Fibrosis Drugs Price by Region (2013-2018)

4 United States Cystic Fibrosis Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Cystic Fibrosis Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Cystic Fibrosis Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Cystic Fibrosis Drugs Price by Type (2013-2018)
4.4 United States Cystic Fibrosis Drugs Sales Growth Rate by Type (2013-2018)

5 United States Cystic Fibrosis Drugs Sales (Volume) by Application (2013-2018)
5.1 United States Cystic Fibrosis Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Cystic Fibrosis Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Cystic Fibrosis Drugs Players/Suppliers Profiles and Sales Data
6.1 Actavis
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche
6.2.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Gilead Sciences
6.3.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Vertex Pharmaceuticals
6.5.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Abbott
6.6.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Anthera Pharmaceuticals
6.7.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Arcturus Therapeutics
6.8.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Boehringer Ingelheim
6.9.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Chiesi Farmaceutici
6.10.2 Cystic Fibrosis Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Corbus Pharmaceuticals
6.12 Genzyme
6.13 Insmed
6.14 Johnson & Johnson
6.15 Merck Sharp & Dohme
6.16 Neovii Biotech
6.17 Novo Nordisk
6.18 PharmaSwiss
6.19 Pharmaxis
6.20 Proteostasis Therapeutics
6.21 PTC Therapeutics
6.22 United Medical
6.23 Venus Remedies

7 Cystic Fibrosis Drugs Manufacturing Cost Analysis
7.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cystic Fibrosis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cystic Fibrosis Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Cystic Fibrosis Drugs Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Cystic Fibrosis Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Cystic Fibrosis Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Cystic Fibrosis Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Cystic Fibrosis Drugs Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Cystic Fibrosis Drugs
Figure United States Cystic Fibrosis Drugs Market Size (K Pcs) by Type (2013-2025)
Figure United States Cystic Fibrosis Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Oral Product Picture
Figure Injection Product Picture
Figure United States Cystic Fibrosis Drugs Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Cystic Fibrosis Drugs by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Cystic Fibrosis Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Cystic Fibrosis Drugs Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Cystic Fibrosis Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Cystic Fibrosis Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Cystic Fibrosis Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Cystic Fibrosis Drugs Sales Share by Players/Suppliers
Figure 2017 United States Cystic Fibrosis Drugs Sales Share by Players/Suppliers
Figure United States Cystic Fibrosis Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Cystic Fibrosis Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Cystic Fibrosis Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Cystic Fibrosis Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Cystic Fibrosis Drugs Revenue Share by Players/Suppliers
Table United States Market Cystic Fibrosis Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Cystic Fibrosis Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Cystic Fibrosis Drugs Market Share of Top 3 Players/Suppliers
Figure United States Cystic Fibrosis Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cystic Fibrosis Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cystic Fibrosis Drugs Product Category
Table United States Cystic Fibrosis Drugs Sales (K Pcs) by Region (2013-2018)
Table United States Cystic Fibrosis Drugs Sales Share by Region (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Share by Region (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Market Share by Region in 2017
Table United States Cystic Fibrosis Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Cystic Fibrosis Drugs Revenue Share by Region (2013-2018)
Figure United States Cystic Fibrosis Drugs Revenue Market Share by Region (2013-2018)
Figure United States Cystic Fibrosis Drugs Revenue Market Share by Region in 2017
Table United States Cystic Fibrosis Drugs Price (USD/Pcs) by Region (2013-2018)
Table United States Cystic Fibrosis Drugs Sales (K Pcs) by Type (2013-2018)
Table United States Cystic Fibrosis Drugs Sales Share by Type (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Share by Type (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Market Share by Type in 2017
Table United States Cystic Fibrosis Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Cystic Fibrosis Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Cystic Fibrosis Drugs by Type (2013-2018)
Figure Revenue Market Share of Cystic Fibrosis Drugs by Type in 2017
Table United States Cystic Fibrosis Drugs Price (USD/Pcs) by Types (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Growth Rate by Type (2013-2018)
Table United States Cystic Fibrosis Drugs Sales (K Pcs) by Application (2013-2018)
Table United States Cystic Fibrosis Drugs Sales Market Share by Application (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Market Share by Application (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Market Share by Application in 2017
Table United States Cystic Fibrosis Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Cystic Fibrosis Drugs Sales Growth Rate by Application (2013-2018)
Table Actavis Basic Information List
Table Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Actavis Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Actavis Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Actavis Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Gilead Sciences Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Gilead Sciences Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Gilead Sciences Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Novartis Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Novartis Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Vertex Pharmaceuticals Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Abbott Basic Information List
Table Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Abbott Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Abbott Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Abbott Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Anthera Pharmaceuticals Basic Information List
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Anthera Pharmaceuticals Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Arcturus Therapeutics Basic Information List
Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arcturus Therapeutics Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Arcturus Therapeutics Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Arcturus Therapeutics Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Chiesi Farmaceutici Basic Information List
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Chiesi Farmaceutici Cystic Fibrosis Drugs Sales Growth Rate (2013-2018)
Figure Chiesi Farmaceutici Cystic Fibrosis Drugs Sales Market Share in United States (2013-2018)
Figure Chiesi Farmaceutici Cystic Fibrosis Drugs Revenue Market Share in United States (2013-2018)
Table Corbus Pharmaceuticals Basic Information List
Table Genzyme Basic Information List
Table Insmed Basic Information List
Table Johnson & Johnson Basic Information List
Table Merck Sharp & Dohme Basic Information List
Table Neovii Biotech Basic Information List
Table Novo Nordisk Basic Information List
Table PharmaSwiss Basic Information List
Table Pharmaxis Basic Information List
Table Proteostasis Therapeutics Basic Information List
Table PTC Therapeutics Basic Information List
Table United Medical Basic Information List
Table Venus Remedies Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cystic Fibrosis Drugs
Figure Manufacturing Process Analysis of Cystic Fibrosis Drugs
Figure Cystic Fibrosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cystic Fibrosis Drugs Major Players/Suppliers in 2017
Table Major Buyers of Cystic Fibrosis Drugs
Table Distributors/Traders List
Figure United States Cystic Fibrosis Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Cystic Fibrosis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Cystic Fibrosis Drugs Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Cystic Fibrosis Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Cystic Fibrosis Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Cystic Fibrosis Drugs Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Cystic Fibrosis Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Cystic Fibrosis Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Cystic Fibrosis Drugs Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Cystic Fibrosis Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Cystic Fibrosis Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Cystic Fibrosis Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Cystic Fibrosis Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.